not tagged
Kiniksa
[]
#acr22 abstracts now available: view new phase 2 study with our investigational anti-cd40 monoclonal antibody. lead authors, pupim l, burmester g, et al. virtual poster available at: 
Every Second Counts!

Kiniksa is a biopharmaceutical company focused on therapeutic medicines for immunological diseases with significant unmet medical need.